| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.873 | 67.031 | 53.101 | 48.035 | 7.485 | 4.135 | 4.043 | 0 | 0 | 5.431 |
| Total Income - EUR | 58.294 | 68.576 | 54.252 | 48.317 | 8.210 | 4.135 | 4.043 | 0 | 0 | 5.455 |
| Total Expenses - EUR | 26.058 | 28.139 | 32.417 | 19.113 | 5.795 | 3.018 | 2.681 | 9.108 | 460 | 6.841 |
| Gross Profit/Loss - EUR | 32.236 | 40.437 | 21.835 | 29.204 | 2.415 | 1.117 | 1.362 | -9.108 | -460 | -1.386 |
| Net Profit/Loss - EUR | 30.538 | 39.096 | 21.293 | 28.722 | 2.169 | 993 | 1.244 | -9.108 | -460 | -1.386 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medinvest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.578 | 846 | 4.422 | 4.557 | 9.252 | 8.075 | 6.990 | 0 | 0 | 855 |
| Current Assets | 95.451 | 47.662 | 42.362 | 64.061 | 4.862 | 6.070 | 8.902 | 5.919 | 1.087 | 5.066 |
| Inventories | 0 | 0 | 552 | 0 | 0 | 0 | 0 | 0 | 0 | 1.608 |
| Receivables | 4.341 | 4.746 | 216 | 497 | 4.807 | 4.144 | 4.815 | 23 | 4 | 202 |
| Cash | 91.110 | 42.916 | 41.594 | 63.564 | 54 | 1.925 | 4.086 | 5.896 | 1.083 | 3.256 |
| Shareholders Funds | 89.737 | 39.195 | 41.736 | 63.267 | 6.250 | 7.124 | 8.209 | -874 | -1.330 | -2.709 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.292 | 9.313 | 5.049 | 5.351 | 7.864 | 7.021 | 7.682 | 6.793 | 2.418 | 8.630 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2551 - 2551" | |||||||||
| CAEN Financial Year |
2561
|
|||||||||
Comments - Medinvest Srl